Recent Press Releases

Charles River Laboratories Adds Craig B. Thompson, M.D. to Board of Directors

WILMINGTON, Mass.-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of Craig B. Thompson, M.D., President and Chief Executive Officer, Memorial...

Venn Life Sciences Holdings Plc ("Venn" or the "Company") Acquisition of Belfast based CRO

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device...

Agilux Laboratories Announces Space Expansion to Support Increasing Demand for Its In Vivo Pharmacokinetics Services

WORCESTER, Mass.--Agilux Laboratories, a leading provider of Drug Metabolism and Pharmacokinetics (DMPK) services to pharmaceutical and biotechnology firms, announced today that it has undergone a...

SARAH CANNON RESEARCH INSTITUTE ANNOUNCES ACQUISITION OF CLINICAL DEVELOPMENT GROUP

NASHVILLE, TN – Sarah Cannon Research Institute (SCRI) announced today the acquisition of Clinical Development Group (CDG), a strategic clinical trial consulting firm based in New Haven, CT. By...

inVentiv Health Hires Senior Life Sciences Executive to Oversee Expansion of Multi-faceted Operations in India

BURLINGTON, Mass.-- inVentiv Health, offering best-in-class clinical, commercial and consulting services to the biopharmaceutical industry, has named a senior executive in India's life sciences...

Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer

REDWOOD CITY, Calif. and CRAIGAVON, United Kingdom -- Genomic Health, Inc. (Nasdaq:GHDX) and ALMAC GROUP Ltd jointly announced today that Genomic Health will exclusively license Almac Group's...

Aptuit Names Jonathan Goldman As CEO

GREENWICH, Conn., Dec. 2, 2013 -- Timothy C. Tyson, Chairman of Aptuit LLC, announced today the appointment of Jonathan Goldman, MD as Chief Executive Officer (CEO), completing the company's...

SillaJen Announces Agreement to Acquire Jennerex, Inc.

BUSAN, South Korea & SAN FRANCISCO--SillaJen, Inc., a privately-held biotherapeutics and contract research company focused on the development of targeted biological products for cancer, announced...

Evoke Pharma Selects SynteractHCR as Contract Research Organization for Phase 3 Trial of EVK-001 for Gastroparesis

SAN DIEGO -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced the selection of SynteractHCR, Inc. to...

Quintiles Infosario Safety System Wins Best Technological Development

RESEARCH TRIANGLE PARK, N.C. – Quintiles has received Scrip Awards' Best Contract Research Organization honors for the second year running, and Best Technological Development in Clinical...

Harlan Laboratories Announces Expansion of Imaging Services and Availability of Disease-Validated Models at Israel Research Center

INDIANAPOLIS -- Harlan Laboratories, a leading contract research organization and research models and services company, is pleased to announce that the company has expanded its disease-preconditioned...

Pharmacyclics and Catalent Solidify Partnership on the Recently Approved Oncology Therapy, IMBRUVICA™

Somerset, NJ —Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, today announced it has...

ResearchDx, the Leading Contract Diagnostics Organization, Expands Operations into India

MUMBAI--ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Indian biopharmaceutical and diagnostics markets. As part of this...

Covance Central Laboratories and NeoGenomics Enter into Exclusive Alliance to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials

PRINCETON, N.J. and FT. MYERS, Fla. -- Covance Inc. (NYSE: CVD), one of the world's largest and most comprehensive drug development services companies, and NeoGenomics, Inc. (NASDAQ: NEO), a...

Vietnam Ministry of Health and Quintiles Collaborate to Advance Clinical Trial Excellence

SINGAPORE – 20 November 2013 – The Vietnam Ministry of Health's Administration of Science, Technology and Training (ASTT) has signed an agreement with Quintiles to enhance clinical...

DATATRAK International, Inc. Reports Record Breaking Third-Quarter 2013 Results

$22M in Backlog Sets Company Record Net Profit Driven by Strong Sales CLEVELAND -- DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified eClinical(R)...

WuXi PharmaTech to Partner with Pharmacyclics

SHANGHAI -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today...

Catalent's Clinical Trial Supply Facility in Shanghai, China Opens for Business

Somerset, NJ – Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, today announced that...

Quintiles Advances Risk-based Monitoring with the Launch of Data-driven Trial Execution Powered by Infosario™ Clinical

New offering improves the quality and predictability of clinical development while reducing overall trial costs by up to 25 percent RESEARCH TRIANGLE PARK, NC – Quintiles today announced the...

ICON Launches New Analytics Service for Advanced Medical Review of Laboratory Data

CONIK Labs allows visualisation, analysis and reporting on laboratory data in real time Dublin, Ireland, 13 November, 2013 – ICON plc, (NASDAQ: ICLR) a global provider of outsourced...